Latest News

12345678910
Spotlight on SoFi Techs: Analyzing the Surge in Options Activitybenzinga.com
Via Benzinga · January 14, 2025
Here's How Much $1000 Invested In Fiserv 20 Years Ago Would Be Worth Todaybenzinga.com
Via Benzinga · January 14, 2025
Trump Wants Trade Partners To 'Start Paying,' Plans External Revenue Service To Oversee Tariffsbenzinga.com
Donald Trump continued his crusade for more tariffs from trade partners with the announced creation of the External Revenue Service.
Via Benzinga · January 14, 2025
Why Robinhood Stock Was Moving Higher Todayfool.com
Via The Motley Fool · January 14, 2025
India's Currency Crisis Is Spreadingtalkmarkets.com
The rupee’s currency crisis is accelerating. The central bank is burning through reserves at an unsustainable pace.
Via Talk Markets · January 14, 2025
Spotlight on FTAI Aviation: Analyzing the Surge in Options Activitybenzinga.com
Via Benzinga · January 14, 2025
Here's How Much You Would Have Made Owning Eaton Corp Stock In The Last 20 Yearsbenzinga.com
Via Benzinga · January 14, 2025
P/E Ratio Insights for Cloroxbenzinga.com
Via Benzinga · January 14, 2025
If You Invested $1000 In This Stock 15 Years Ago, You Would Have This Much Todaybenzinga.com
Via Benzinga · January 14, 2025
JPMorgan Vs. Wells Fargo: 1 Stock Technically Stronger Ahead Of Earningsbenzinga.com
JPM and WFC are preparing to release their Q4 earnings, with strong bullish momentum for JPM and cautionary signals for WFC. Analysts forecast positive results for JPM, while WFC may experience a minor pullback. The long-term bullish trend remains intact for both.
Via Benzinga · January 14, 2025
Nature Mirale Shares Are Rising Today: What's Going on?benzinga.com
Nature's Miracle Holding Inc. (NASDAQNMHI) shares are trading higher Tuesday after announcing that it had entered into a Securities Purchase Agreement (SPA) with a single institutional investor.
Via Benzinga · January 14, 2025
'I'm Watching My Retirement Savings Erode Away!' – 61-Year-Old Panics Over His Investments But Dave Ramsey Tells Him 'Shut Up And Invest'benzinga.com
Via Benzinga · January 14, 2025
BridgeBio Pharma Stock Earns 87 RS Ratinginvestors.com
BridgeBio Pharma stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an increase from 64 to 87.
Via Investor's Business Daily · January 14, 2025
Bitcoin, Ethereum, XRP, Dogecoin Move Higher Ahead Of Inflation Data Wednesdaybenzinga.com
Cryptocurrency markets are seeing gains across the board despite ongoing ETF outflows, indicating underlying strength in the market.
Via Benzinga · January 14, 2025
What's going on in today's session: S&P500 most active stockschartmill.com
Let's have a look at the most active S&P500 stocks in today's session.
Via Chartmill · January 14, 2025
Where Starwood Prop Trust Stands With Analystsbenzinga.com
Via Benzinga · January 14, 2025
A Glimpse Into The Expert Outlook On Hartford Finl Servs Gr Through 6 Analystsbenzinga.com
Via Benzinga · January 14, 2025
Expert Outlook: Payoneer Global Through The Eyes Of 10 Analystsbenzinga.com
Via Benzinga · January 14, 2025
American Electric Power Stock Sees RS Rating Improve To 72investors.com
American Electric Power stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an upgrade from 67 to 72.
Via Investor's Business Daily · January 14, 2025
Visualizing America’s $1.7 Trillion Insurance Industrytalkmarkets.com
As of Jan. 7, 2025, UnitedHealth Group is the country’s most valuable insurance company, with a market cap of $473 billion.
Via Talk Markets · January 14, 2025
Bank of America Highlights Ferrari, Aptiv and AutoNation as Top Auto Stocks for 2025benzinga.com
Bank of America has identified three key auto stocks it expects to outperform in 2025: Ferrari (RACE), Aptiv Inc. (NYSEAPTV) and AutoNation Inc. NYSE: ANNYSEAN)
Via Benzinga · January 14, 2025
A Deep Dive On The Recent Spike In U.S. Treasury Yieldstalkmarkets.com
U.S. Treasury yields have increased notably since September, particularly at the long end of the curve, with the 10-year yield up over 100 basis points from its recent lows.
Via Talk Markets · January 14, 2025
Under the Radar: The Importance of Book Value Growth in Assessing Company Stabilitybenzinga.com
Via Benzinga · January 14, 2025
What Analysts Are Saying About Evolent Health Stockbenzinga.com
Via Benzinga · January 14, 2025
Unpacking the Latest Options Trading Trends in Alphabetbenzinga.com
Via Benzinga · January 14, 2025
Shell Unusual Options Activity For January 14benzinga.com
Via Benzinga · January 14, 2025
Breaking Down Oshkosh: 5 Analysts Share Their Viewsbenzinga.com
Via Benzinga · January 14, 2025
Where WR Berkley Stands With Analystsbenzinga.com
Via Benzinga · January 14, 2025
Here's How Much $100 Invested In ServiceNow 10 Years Ago Would Be Worth Todaybenzinga.com
Via Benzinga · January 14, 2025
Most active stocks in Tuesday's sessionchartmill.com
Stay updated with the latest market activity on Tuesday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.
Via Chartmill · January 14, 2025
What Is The Economic Outlook For 2025?talkmarkets.com
With 2024 now behind us, the year ahead promises to be all the more dramatic.
Via Talk Markets · January 14, 2025
Silver’s Time To Shine Is Here – Get Readycontent/com
Silver tends to outperform the rest of the precious metals sector close to the end of a given rally. We’re not there yet.
Via Talk Markets · January 14, 2025
Mastercard Is Fairly Valued And Lacks An Identifiable Catalyst; Analyst Downgrades Stockbenzinga.com
Analyst downgraded Mastercard to Neutral with $521 PT. Revenue upside limited due to international exposure. No catalysts this year.
Via Benzinga · January 14, 2025
Why Tesla Stock Jumped Tuesdayfool.com
Via The Motley Fool · January 14, 2025
(WELL) - Analyzing Welltower's Short Interestbenzinga.com
Via Benzinga · January 14, 2025
How Is The Market Feeling About Sysco?benzinga.com
Via Benzinga · January 14, 2025
PACCAR To Generate Over 5% Dividend Yield In 2026, Analyst Sees New Peak EPSbenzinga.com
BofA upgrades PACCAR to Buy, projects a new peak EPS of $10.25 in 2026, and a 5% dividend yield amid truck market recovery.
Via Benzinga · January 14, 2025
Vertex Pharmaceuticals Sets Sight on Expanding Portfolio with Alyftrek Approval, Pain Treatment Progress, and Diabetes Trialsbenzinga.com
Vertex secures FDA approval for ALYFTREK and expands TRIKAFTA use, advances diabetes and kidney disease therapies, and strengthens its global drug pipeline.
Via Benzinga · January 14, 2025
How Is The Market Feeling About Tetra Tech?benzinga.com
Via Benzinga · January 14, 2025
Options Corner: Wait Out Rumble's Choppiness Before Diving Inbenzinga.com
While video-sharing platform Rumble is tanking, speculators have a tendency of buying extreme-fear events in RUM stock.
Via Benzinga · January 14, 2025
Bitcoin Is An 'Excellent' Buying Opportunity At If It Breaks Below $90,000 Says Standard Charteredbenzinga.com
Bitcoin (CRYPTO: BTC) could potentially fall to the low $80,000s if it breaks decisively below $90,000, according to Standard Chartered<
Via Benzinga · January 14, 2025
Small Business Expectations Vs. Realitytalkmarkets.com
Small business optimism has now surged 11.4 points since the October report, which is a record two-month increase in the history of the survey going back to 1986. 
Via Talk Markets · January 14, 2025
Peering Into KeyCorp's Recent Short Interestbenzinga.com
Via Benzinga · January 14, 2025
(THC) - Analyzing Tenet Healthcare's Short Interestbenzinga.com
Via Benzinga · January 14, 2025
Peering Into Tilray Brands's Recent Short Interestbenzinga.com
Via Benzinga · January 14, 2025
Alphabet Analyst Says 2025 ‘Pivotal’ Year For Stock As Opportunities And Challenges Abound: Retail Sentiment Brightensstocktwits.com
BofA’s Justin Post said 2025 could establish Alphabet as an artificial intelligence leader or expose the company to elevated search disruption.
Via Stocktwits · January 14, 2025
AI Drug Discovery Startups: Atomwise Focuses On AI-Based Small Molecule Discoverytalkmarkets.com
Atomwise was founded in 2012 with the intention of finding cures for common and orphan diseases that are too expensive and time-intensive for pharma companies to find a cure for.
Via Talk Markets · January 14, 2025
BP Signals Weaker Fourth-Quarter Earnings: Retail Sentiment Soursstocktwits.com
London-based BP said weak margins would cut its refining earnings between $100 million and $300 million compared to the third quarter.
Via Stocktwits · January 14, 2025
EXCLUSIVE: Energy, Semiconductors Could Dominate Portfolios In 2025, Says Direxion CEObenzinga.com
Direxion CEO Douglas Yones sees tech and energy as growth areas in 2025. Semiconductors driven by AI demand, energy boosted by favorable policies.
Via Benzinga · January 14, 2025
US Global Investors Shines In 2024: JETS ETF Soars 33% Amid Travel Boom; Gold, Shipping Funds Add To Gainsbenzinga.com
U.S. Global Investors celebrates a successful year with its JETS ETF soaring 33%, TSA screening 5% more passengers and United Airlines stock rising 135%.
Via Benzinga · January 14, 2025